Business Wire

OR-USB-IF

Share
USB Implementers Forum (USB-IF) Launches New Conformity Test Program for OEMs/ODMs in Support of EU Common Charger Directive

USB Implementers Forum (USB-IF), the support organization for the advancement and adoption of USB technology, today announced the launch of the USB-IF Conformity to IEC 62680 (USB) Specifications Program. This new initiative is designed to assist Original Equipment Manufacturers (OEMs)/Original Device Manufacturers (ODMs) in conforming to the basic requirements of the European Union (EU) Common Charger Directive, which mandates the use of standardized charging technology across a wide range of portable battery-powered devices in the EU.

In response to the EU's 2022 approval of the common charger directive—which will take effect on January 1, 2025, for portable battery-powered devices and in 2026 for laptops—the USB-IF Conformity to IEC 62680 (USB) Specifications Program specifically addresses key aspects of the directive. These include portable battery-powered devices, USB Type-C® receptacles, USB Type-C cables and connectors, external power supplies (EPS), and the USB Power Delivery (USB PD) protocol for devices advertising more than 15 Watts.

“The USB-IF has enjoyed a longstanding relationship with IEC. We contributed the core USB specifications to IEC which, once adopted, became the IEC 62680 series of USB specifications,” said USB-IF President and Chief Operating Officer Jeff Ravencraft. “The EU mandate covers only a portion of the entire USB specifications. As the industry group responsible for developing and overseeing all aspects of the USB specifications and testing, the USB-IF's new program is designed to assist OEMs/ODMs in demonstrating conformity with the EU’s requirements of the common charger directive.”

The USB-IF Conformity to IEC 62680 (USB) Specifications Program creates a simple, cost-effective process for OEMs/ODMs to demonstrate conformity to the EU Common Charger Directive. Using the USB-IF program, OEMs/ODMs can have their USB Type-C products formally tested by USB-IF authorized independent test labs (ITLs). Upon successful completion of testing, OEMs/ODMs will receive documentation to demonstrate to the EU that their products conform to the IEC 62680 (USB) specifications. This streamlined process allows for a quick testing turnaround, ensuring that manufacturers can meet regulatory deadlines:

  • OEMs will continue to register their products and submit test results through ITLs, following USB-IF’s already established process.
  • A minimum set of required tests has been defined by the USB-IF to demonstrate baseline conformity.
  • The USB-IF will review all test result submissions and provide official approval.
  • A Vendor ID (VID) is required, and USB-IF will be utilizing a Test ID (TID) as a tracker reference.

"The USB-IF Conformity to IEC 62680 (USB) Specifications Program has been crafted to ensure that all submitted products undergo evaluation, focusing on the critical elements we believe are necessary for conforming with the EU mandate,” said USB-IF Chief Technology Officer and Chairman of the Board Abdul Ismail. “Our testing levels are designed to offer a precise and reliable assessment, enabling OEMs/ODMs to confidently show to the EU that their products conform to the regulatory obligations."

While the USB-IF Conformity to IEC 62680 (USB) Specifications Program provides a vital service to OEMs/ODMs by offering a formal method to demonstrate conformity to EU mandates, it is important to distinguish this from the more extensive USB-IF Compliance Program. The USB-IF Compliance Program offers in-depth testing that not only establishes conformity with the IEC 62680 specifications but also fully verifies a product's adherence to the comprehensive USB-IF specifications for data performance, reliability and interoperability. Additionally, fully certified products qualify to be able to use the Certified USB Logo, which consumers recognize and trust to provide what they have come to expect from USB products.

“While this program is not a full certification of USB technologies, it provides a formalized pathway for OEMs/ODMs to test their products quickly,” said Ravencraft. “We are confident this new program will help the industry achieve conformity so they can continue to sell their products in the EU marketplace."

An online public listing of OEMs/ODMs products that have passed the "USB-IF Conformity to IEC 62680 (USB) Specifications Program" is located on the USB-IF product search page at www.usb.org. This platform also differentiates between products that are fully USB-IF certified and those that have met only the conformity requirements.

About USB-IF

The non-profit USB Implementers Forum, Inc. was formed to provide a support organization and forum for the advancement and adoption of USB technology as defined in the USB specifications. USB-IF facilitates the development of high-quality compatible USB devices through its logo and compliance program and promotes the benefits of USB and the quality of products that have passed compliance testing. Further information, including postings of the most recent product and technology announcements, is available by visiting the USB-IF website at www.usb.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240827576634/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

1NCE Continues Growth and Expands Its Software, AI and Services Offering7.1.2026 14:15:00 CET | Press release

In 2025 1NCE added another 10 million endpoints to its foundational IoT platform; now manages 40+ million intelligent products for 30,000 customers in 17 industries. Introduces new software, 1NCE Insights, the AI + IoT fusion of intelligence from its network that gives analytics and benchmark data on how customers can better setup, manage and optimize their device estates. 1NCE, a company offering a plug-and-play platform for creating and managing the world’s best IoT products, reports another strong growth year, adding another 10 million endpoints. The company now manages 40+ million intelligent products for 30,000+ customers across 17 industries. 1NCE’s software and connectivity platform has become a new industry standard, delivering hassle-free IoT in 170+ countries and regions. The company has a unique vantage point in the IoT ecosystem, with four billion data records per day collected through 250+ streams on the world’s largest IoT network in the cloud. The company launched a new

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 14:00:00 CET | Press release

Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 12:30:00 CET | Press release

FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by the end of the year for COMP360 for treatment-resistant depression (TRD)Management will host webinar with KOL and industry leaders to discuss PTSD clinical trial and commercial preparations for TRD from 10:00-11:30 am ET on January 7th Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations f

Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 11:07:00 CET | Press release

Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,

ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 10:00:00 CET | Press release

CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye